Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
Lupin
Lupin Rises 7% As Kotak Upgrades Stock On Healthy U.S. Sales Forecast
Shares of Lupin rose 7% on Thursday as Kotak expects 12% YoY growth of $914 million in US sales in FY25.
Disney, Reliance Finalise Merger, Pharma Firms Recall Drugs From US And Other Stories From The Weekend You Can't Miss
This Large Cap Pharma Firm Is Up 5% Today—Analysts See Further 20% Upside
Lupin Rises 7% As Kotak Upgrades Stock On Healthy U.S. Sales Forecast
Disney, Reliance Finalise Merger, Pharma Firms Recall Drugs From US And Other Stories From The Weekend You Can't Miss
This Large Cap Pharma Firm Is Up 5% Today—Analysts See Further 20% Upside
Sajjan Jindal's Denial Of Sexual Assault Claim, Adani's IANS Takeover And Other Stories From Weekend You Can't Miss
|
All the top stories from the weekend in one convenient spot.
US FDA Plans To Keep Indian Pharma On Toes With More Surprise Inspections: Report
|
During the COVID-19 pandemic, inspections of Indian pharmaceutical manufacturing facilities by the US FDA decreased. However, a US House panel expressed concerns in July regarding the FDA's oversight of manufacturing facilities in India and China and its reliance on foreign drug manufacturers.
